These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37496220)

  • 41. New therapies for locoregionally advanced and locoregionally recurrent head and neck cancer.
    Wenig BL
    Cancer Treat Res; 2003; 114():315-30. PubMed ID: 12619548
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunotherapy in head and neck squamous cell carcinoma: An updated review.
    Parmar K; Mohamed A; Vaish E; Thawani R; Cetnar J; Thein KZ
    Cancer Treat Res Commun; 2022; 33():100649. PubMed ID: 36279709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma.
    Baxi SS; Dunn LA; Burtness BA
    Oral Oncol; 2016 Nov; 62():147-148. PubMed ID: 27776933
    [No Abstract]   [Full Text] [Related]  

  • 44. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Haring CT; Kana LA; Dermody SM; Brummel C; McHugh JB; Casper KA; Chinn SB; Malloy KM; Mierzwa M; Prince MEP; Rosko AJ; Shah J; Stucken CL; Shuman AG; Brenner JC; Spector ME; Worden FP; Swiecicki PL
    Cancer; 2023 Sep; 129(18):2817-2827. PubMed ID: 37162461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review.
    Guidi A; Codecà C; Ferrari D
    Med Oncol; 2018 Feb; 35(3):37. PubMed ID: 29441454
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients.
    Fukuda N; Yunokawa M; Fujiwara Y; Wang X; Ohmoto A; Hayashi N; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1322. PubMed ID: 33295110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncogenic virus in oral squamous cell carcinoma and the role of oncolytic HSV-1 viro-immunotherapy as an emerging treatment.
    Saravanan M; Kolade Omole R; Torimiro N
    Oral Oncol; 2022 Oct; 133():106021. PubMed ID: 35868096
    [No Abstract]   [Full Text] [Related]  

  • 48. A New Approach to Survival Analysis of Head and Neck Squamous Cell Carcinoma.
    Masoudi S; Montazeri SA; Pourdanesh F; Biglarian A; Kazemi M; Rahgozar M
    Arch Iran Med; 2017 Aug; 20(8):503-510. PubMed ID: 28846014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial.
    Guo Y; Shi M; Yang A; Feng J; Zhu X; Choi YJ; Hu G; Pan J; Hu C; Luo R; Zhang Y; Zhou L; Cheng Y; Lüpfert C; Cai J; Shi Y
    Head Neck; 2015 Aug; 37(8):1081-7. PubMed ID: 24710768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pseudoprogression during Immunotherapy in Metastatic Head and Neck Squamous Cell Carcinoma.
    Bedmutha A; Kaushal A
    Radiol Imaging Cancer; 2022 May; 4(3):e220037. PubMed ID: 35549358
    [No Abstract]   [Full Text] [Related]  

  • 52. Reirradiation with cetuximab in locoregional recurrent and inoperable squamous cell carcinoma of the head and neck: feasibility and first efficacy results.
    Balermpas P; Keller C; Hambek M; Wagenblast J; Seitz O; Rödel C; Weiss C
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e377-83. PubMed ID: 22414284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck - a case series and review of literature.
    Olmos M; Lutz R; Büntemeyer TO; Glajzer J; Nobis CP; Ries J; Möst T; Eckstein M; Hecht M; Gostian AO; Erdmann M; Foerster Y; Kesting M; Weber M
    Front Immunol; 2022; 13():970823. PubMed ID: 36389668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    Sacco AG; Cohen EE
    J Clin Oncol; 2015 Oct; 33(29):3305-13. PubMed ID: 26351341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene therapy for head and neck cancers.
    Lamont JP; Kuhn JA; Nemunaitis JJ; McCarty TM
    Oncology (Williston Park); 2001 Mar; 15(3):303-8; discussion 311-4. PubMed ID: 11301829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preliminary experience in salvage treatment for advanced recurrent cancers of the head and neck].
    Jiang PJ; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):58-60. PubMed ID: 1889340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Head and neck cancer : promising results of immunotherapy].
    Sivade A; Bensaid D; Monnier Y; Shabafrouz K; Bouchaab H; Cristina V
    Rev Med Suisse; 2017 May; 13(563):1029-1031. PubMed ID: 28636292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma.
    Becherini C; Banini M; Desideri I; Salvestrini V; Caprara L; Scotti V; Ganovelli M; Morelli I; Romei A; Livi L; Bonomo P
    J Geriatr Oncol; 2023 Jan; 14(1):101380. PubMed ID: 36175350
    [No Abstract]   [Full Text] [Related]  

  • 60. Unresectable Recurrent Squamous Cell Carcinoma of the Temporal Bone Treated by Induction Chemotherapy Followed by Concurrent Chemo-Reirradiation: A Case Report and Review of the Literature.
    Kun M; Xinxin Z; Feifan Z; Lin M
    Otol Neurotol; 2015 Sep; 36(9):1543-6. PubMed ID: 26208130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.